Ukrainian technology will be used to print human bones in US hospitals!
The groundbreaking technology developed by an Odesa-based firm ADAM Bioprinting will enter the medical devices and implants market in the US which is estimated to be worth $180.
- In 2018, Kwambio Ukrainian 3D printer manufacturer, together with WeFund Ventures presented their joint human bone and organ printing project ADAM.
- A.D.A.M. is a developer of an on-demand personalized implant manufacturing infrastructure with a full scope of related services, provided remotely or on-site.
- A.D.A.M. uses its proprietary 3D-printing technology and patented materials to manufacture bioresorbable and biodegradable patient-specific implants (primarily, bone implants), which can be scalably and cheaply produced and used.
- In August, 2020, FDA confirmed 510(k) eligibility for A.D.A.M. biopolymer and bioceramic bone implants. No human trials are required. FDA clearance is expected in 2022.
- Recently, the team has been accepted to join the Technology Incubation Program at the University of Connecticut in Farmington, CT. Their HQs – Research & Development lab moved our main office there as TIP offers state of the art research facilities and resources to its member companies.
via Ukraine Business News